Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid for Endothelial Function in HIV and HIV-HCV Patients
NCT02810275Phase 3Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Oct 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of folinic acid in atherosclerosis, cardiovascular disease (CVD), sponsored by Hospital de Clínicas de Porto Alegre. Started Oct 2012; status: completed.
02
Drugs
folinic acid
03
Conditions
atherosclerosiscardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02810275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810275.